MedTrace Logo

Bilateral Dual Transversus Abdominis Plane Block for Robotic Assisted Laparoscopic Surgery

NCT01760161 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2015-05-12

No results posted yet for this study

Summary

To evaluate the effects of bilateral dual transversus abdominis plane block on postoperative pain after robotic assited laparoskopic surgery and measure the plasma-level of ropivacain after the bilateral dual transversus abdominis plane block.

Conditions

  • Pain Treatment
  • Robotic Assisted Laparoscopic Surgery
  • Bilateral Dual Transversus Abdominis Plane Block

Interventions

DRUG

Ropivacaine

Ropicacain 3,75 mg/ml 15 ml x 4 when placing the Bilateral Dual Transverus Abdominis Plane block

DRUG

Isotonic potassium chloride

Isotonic potassium chloride 15 ml x 4 when placing the bilateral dual transverus abdominis plane block.

Sponsors & Collaborators

  • Aalborg University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-12-31
Completion
2016-02-29

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01760161 on ClinicalTrials.gov